Journal Information

The Journal of Reports in Pharmaceutical Sciences (ISI indexed) publishes peer-reviewed, multidisciplinary research across pharmaceutical sciences.

JIF 2025

0.2

CiteScore 2023

1.4

Accept to publication

11 days

Acceptance rate

27%

The record

Full journal title
Journal of Reports in Pharmaceutical Sciences
Abbreviation
jrps
NLM title
J Rep Pharm Sci
Publisher
Brieflands
Scientific collaborator
Faculty of Pharmacy, Kermanshah University of Medical Sciences
e-ISSN
2322-5106
Language
English
Frequency
annually
Publishing model
Per-article continuous

Aim & scope

The Journal of Reports in Pharmaceutical Sciences (JRPS) is a continuous, peer-reviewed journal publishing multidisciplinary research that advances pharmaceutical sciences and supports evidence-based practice. JRPS considers original work that is not published or under review elsewhere and prioritizes novelty, methodological rigor, and translational or clinical relevance.

 

Journal Scope

  • Drug discovery & computational design: medicinal chemistry, SAR, molecular modeling, in silico methods, and drug design
  • Pharmaceutics & biopharmaceutics: formulation science, dosage forms, biopharmacy, stability, and performance evaluation
  • Drug delivery & nanotechnology: targeted/controlled delivery systems, nano-enabled platforms, characterization, and in vitro/in vivo assessment
  • Natural products & pharmacognosy: phytochemistry, isolation and characterization of bioactive compounds, standardization, and quality evaluation
  • Pharmaceutical biotechnology: biopharmaceutical development, recombinant technologies, biosimilars, bioprocessing, and formulation aspects of biologics
  • Pharmacology & toxicology: mechanistic pharmacology, experimental therapeutics, safety pharmacology, and toxicological assessment
  • Clinical pharmacy & outcomes: pharmacotherapy, medication safety, drug utilization, adherence, and outcomes/practice-based research

Article types

JRPS accepts the following manuscript types:

  • Original Research Article: Full reports of novel, unpublished findings supported by robust methodology and appropriate analysis.
  • Review Article: Comprehensive, critical syntheses of the literature that identify current evidence, gaps, and future directions.
  • Short Communication: Brief reports of timely, significant findings or preliminary results that merit rapid dissemination.
  • Case Report/Case Series (Clinical Pharmacy): Clinically relevant cases with clear educational value and implications for practice.
  • Letter to the Editor: Concise, evidence-based commentary on recently published articles or topical issues within the journal’s scope.

Peer review

Access & licensing

License policy

This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Publication charges

Refer here

  • Publishing Open Access models: Full Gold Open Access
  • Access: Immediate permanent free to access after publication
  • Reader subscription fees: None
  • Article Processing Charge: Author pays APC
  • Embargo period: None
  • License for reuse: CC BY-NC 4.0
  • Publishing services: Full
  • Indexing: Full

Digital archiving

This journal deposits its articles in Portico to guarantee long-term digital preservation.

Indexing & metrics

Journal Metrics

Discover our most recent insights and updates.

JIF 20250.2
CiteScore 20231.4
Accept to publication11 days
Acceptance rate27%
Open peer review2
ESCIon
Processing chargesMore

This journal is abstracted and indexed by a number of international services.

Complete list of indexing sources

Contact